We examined the bioactivity of Yamato-mana (Brassica rapa L. Oleifera Group) constituent glucosinolates and found that 3-butenyl glucosinolate (gluconapin) decreased the plasma triglyceride gain induced by corn oil administration to mice. However, phenethyl glucosinolate (gluconasturtiin) had little effect. 2-Propenyl glucosinolate (sinigrin) also reduced the plasma triglyceride level, which suggests that alkenyl glucosinolates might be promising agents to prevent postprandial hypertriglyceridemia.
The plasma triglyceride (TG) level is related to cardiovascular disease, 1 ) and a high postprandial TG level is a risk factor for atherosclerotic disease. Most patients with coronary artery disease have an increased postprandial TG level compared to healthy control groups.
2) An excessive postprandial hypertriglyceridemic response indicates poor triglyceride clearance from the bloodstream and is often associated with atherosclerosis, insulin resistance, and obesity.
3) Preventing postprandial hypertriglyceridemia is therefore very important for a healthy life. Yamato-mana (YM, Brassica rapa L. Oleifera Group) is a traditional vegetable from Nara Prefecture in Japan. However, the bioactive compounds from YM have not been satisfactorily studied. In our research of the secondary metabolites from YM, we has isolated and identified 3-butenyl glucosinolate (BUGLS, gluconapin, 0.02%) as a major glucosinolate and phenethyl glucosinolate (PEGLS, gluconasturtiin, 0.005%) as a minor glucosinolate from fresh leaves (100%). BUGLS is an alkenyl glucosinolate and PEGLS is a phenyl glucosinolate. These structures are presented in Fig. 1 . Glucosinolates are -thioglucoside N-hydroxyiminosulfates with a side chain and major secondary metabolites of the crucifer species. Glucosinolates are stable water-soluble compounds, although they are converted to isothiocyanates by endogenous thioglucosidase (myrosinase) upon wounding, cutting, and chopping of the plant. A number of studies on the bioactivities of isothiocyanates have been reported. [4] [5] [6] [7] The endurance enhancing activity 8) and antiamoebic activity 9) of glucosinolates have been reported, however their bioactivity has not been sufficiently examined, because they have been presumed to be relatively biologically inactive.
10) The objective of this study was to examine the bioactivity of YM constituents BUGLS and PEGLS. During in vitro and in vivo screening for their bioactivities to evaluate the effects on lipid digestion and absorption, BUGLS was found to have a suppressive effect on the plasma TG gain induced by a corn oil administration to mice.
Since BUGLS and PEGLS can only be isolated from YM in small amounts, large-scale purification of these compounds was achieved for their use in assays. We found that seeds of YM contained a high concentration of BUGLS by an HPLC analysis, while the isolation of PEGLS in gram-amount from seeds of upland cress (Barbarea verna) has been reported by Barillari et al.
11)
Consequently, both BUGLS and PEGLS were respectively purified from seeds of YM and upland cress by using the method reported by Barillari et al., 11) then used following a few modifications. Seeds of YM were extracted with boiling water. An extract was obtained by centrifugation and deproteinized by adding 1 M Zn(OAc) 2 . The supernatant after centrifugation was subjected to chromatography on a DEAE-Sephadex A-25 column. The concentrated fraction was extracted with boiling methanol, and the extract was centrifuged. The supernatant was added to chilled ethanol, and BUGLS (1.25% of fresh weight) was obtained as a white powder after centrifugation. PEGLS (2.93% of fresh weight) was isolated from seeds of upland cress in the same manner. 2-Propenyl glucosinolate (PPGLS, sinigrin) and 3-butenyl isothiocyanate (BUITC) were respectively obtained from Wako Pure Chemicals (Osaka, Japan) and Tokyo Chemical Industry Co., (Tokyo, Japan).
We evaluated the suppressive effects of BUGLS, PEGLS, BUITC, and PPGLS on TG absorption in lipidloaded mice (experiments 1, 2, and 3) and in an in vitro experiment with lipase. Six-week-old male Slc:ddY mice from SLC (Hamamatsu, Japan) were kept in a y To whom correspondence should be addressed. Fax: +81-744-20-0882; E-mail: kwashida@festa.ocn.ac.jp Biosci. Biotechnol. Biochem., 74 (6), [1286] [1287] [1288] [1289] 2010 Note room maintained at 24 AE 1 C and 50 AE 10% humidity under a 12-h light/dark cycle, and had free access to water and a standard laboratory feed (Labo MR stock, SLC) for 1 week to accustom them to their surroundings. The animal studies were done according to the Guidelines for Animal Experimentation of Tokyo University of Marine Science and Technology with the approval of the Animal Care and Use Committee of this institution. In the experiment 1, for the lipid-loading test, after fasting for 24 h, the mice were divided into groups (n ¼ 8) and orally administered with distilled water (control group) or 40 mmol/kg of a BUGLS or PEGLS solutions, just before the oral corn oil (8 ml/kg) loading. Blood samples were taken from the lateral tail vein at 0, 1, 2, 3, 4, 5, 6, 7, and 8 h after the administration. Plasma was separated by centrifugation in heparinized tubes, and the TG concentration was measured with a Triglyceride E test wako kit (Wako Pure Chemicals, Osaka, Japan). In the experiments 2 and 3, the procedures were similar to those in the experiment 1, except that BUGLS, PPGLS, and BUITC (80 mmol/kg each) for experiment 2, and PEGLS (80 mmol/kg) for experiment 3, were administered as samples to the lipidloaded mice. Data are expressed as the mean AE S.E. and were analyzed by one-way ANOVA and subsequent Dunnett's test. Significance was set at p < 0:05 versus the control group.
The lipase inhibitory activities of BUGLS, BUITC, and PPGLS were measured by using a porcine pancreatic lipase (ICN Biomedicals, Aurora, Ohio, USA) and a Lipase Kit S (Dainippon Sumitomo Pharmaceutical Co., Osaka, Japan) according to the protocol in accompanied manual. The lipase inhibitory effects were calculated as a percentage of the control without samples. Data are expressed as the mean from three different experiments.
In the experiment 1, we evaluated the suppressive effect of BUGLS at 40 mmol (14.9 mg)/kg and PEGLS at 40 mmol (16.9 mg)/kg on the plasma TG gain caused by the corn oil administration. The dose of 40 mmol/kg was calculated from about two times as much as the amount of BUGLS in 1 g of the YM hot-water extract (BUGLS, 17.3 mmol (6.4 mg); PEGLS, 3.8 mmol (1.6 mg)), because this extract at 1 g/kg had tendency to suppress the elevation of plasma TG level in a preliminary experiment. In the results, BUGLS had a tendency to decrease the plasma TG level compared with that of the control group at 4-8 h after administration without statistically significant differences, however, PEGLS did not. This result suggests that the side chains of glucosinolates might be important for reducing the plasma TG level, and alkenyl side chain might be especially desirable.
Thus, in the next experiment, the suppressive effects of glucosinolate and isothiocyanate with an alkenyl side chain and BUGLS were evaluated. PEGLS was also assessed in a separate experiment. To clarify the effect, a double volume of these samples were performed.
In the experiments 2 and 3, the effects of a double volume of BUGLS (80 mmol (29.8 mg)/kg), PPGLS (80 mmol (28.7 mg)/kg), BUITC (80 mmol (9.0 mg)/kg), and PEGLS (80 mmol (33.8 mg)/kg) on the plasma TG gain induced by the corn oil administration were evaluated. PPGLS is an alkenyl glucosinolate similar to BUGLS, and BUITC is a degradation product of BUGLS by myrosinase. The structures of PPGLS and BUITC are shown in Fig. 1 . As shown in Fig. 2A , BUGLS and PPGLS suppressed the elevation of plasma TG level compared with that of the control group at 3-8 h after administration. The area under the concentration curve (AUC) of TG over 8 h was calculated as the index of the total absorbed amount and AUC values are expressed as a percentage of the control group. As shown in Fig. 2B , BUGLS and PPGLS significantly decreased the AUC values of the plasma TG for 8 h to 61:5 AE 6:8% (BUGLS) and 64:0 AE 7:0% (PPGLS) with statistically significant differences compared with the control group in the lipidloaded mice (experiment 2). BUITC had a tendency to reduce the AUC. As shown in Fig. 2C , PEGLS also had a slight tendency to decrease the AUC (87:2 AE 21:7%) in experiment 3. The suppression effect of BUGLS was 3-Butenyl Glucosinolate Suppresses Hypertriglyceridemiastronger than that of BUITC, so we propose that the active form of BUGLS in vivo is not BUITC.
To investigate the effects of BUGLS, PPGLS, and BUITC, an in vitro lipase inhibition test was performed. BUGLS and BUITC showed little inhibitory effects (5.7% for BUGLS and 4.5% for BUITC) on lipase at 4 mM (1.49 mg/ml and 0.45 mg/ml, respectively). PPGLS exhibited no lipase inhibitory effect (À7:4% at 4 mM, 1.44 mg/ml).
In conclusion, the Yamato-mana constituent BUGLS was found to have a suppressive effect on the plasma TG gain caused by a corn oil administration to mice. This is the first report of a glucosinolate showing a suppressive effect on the plasma TG level. Interestingly, PEGLS exhibited little effect. In addition to BUGLS, PPGLS also reduced the plasma TG level, which suggests that alkenyl glucosinolates might be promising agents to prevent postprandial hypertriglyceridemia. Additionally, BUGLS and BUITC showed little lipase inhibitory effects at high concentrations, which suggests that the mechanism of action of their effects on the plasma TG level is not due to the lipase inhibition by BUGLS.
In the previous report, it was shown that tea polyphenols reduced fat absorption by decreasing emulsification. 12) On the other hand, a water extract of Houttuynia cordata leaves suppressed the elevation of plasma TG level by inhibiting the absorption of TG hydrolysates such as fatty acids and glycerols. 13) We therefore propose that BUGLS and PPGLS may have decreased the plasma TG level by inhibiting micelle formation and/or TG hydrolysates absorption in the small intestine.
The mechanisms of action of the suppressive effects on plasma TG gain by glucosinolates and the differences in kinetics between alkenyl glucosinolate and phenyl glucosinolate in vivo are currently being studied. 
